MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 05-23-2026
Quotient Limited Interest Expense 2011-2026 | QTNT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Quotient Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.6 M | 2.72 M | 617 K | -6.94 M | 2.37 M | -1.11 M | 3.5 M | -4.06 M | -197 K | 11 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.6 M | -6.94 M | 852 K |
Quarterly Interest Expense Quotient Limited
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.6 M | -15.2 M | -4.37 M | 20.6 M | -3.51 M | 5.92 M | 9.5 M | -3.51 M | 192 K | 5 M | 233 K | 617 K | 1.89 M | -1.24 M | 952 K | 1.89 M | -1.54 M | -468 K | -3.51 M | -1.54 M | -1.54 M | -468 K | - | 33 K | 33 K | 565 K | 880 K | -4.57 M | 305 K | -657 K | -635 K | 305 K | 130 K | -2.96 M | 534 K | 130 K | -1.49 M | 534 K | - | -45 K | -83 K | 77 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20.6 M | -15.2 M | 589 K |
Interest Expense of other stocks in the Diagnostics research industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
8.42 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
4.19 M | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
81 M | $ 115.84 | 0.68 % | $ 35.2 B | USA |
 |
Celcuity
CELC
|
5.33 M | $ 133.97 | -0.22 % | $ 6.26 B | USA |
|
Akumin
AKU
|
118 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
106 K | $ 7.3 | -19.87 % | $ 9.71 M | USA |
 |
Castle Biosciences
CSTL
|
144 K | $ 21.26 | 7.97 % | $ 616 M | USA |
 |
Aspira Women's Health
AWH
|
1.81 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-595 K | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
153 K | $ 17.9 | 1.3 % | $ 551 M | USA |
 |
Biocept
BIOC
|
316 K | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-10.5 M | $ 127.51 | 6.39 % | $ 16 B | USA |
 |
CareDx, Inc
CDNA
|
524 K | $ 22.16 | 2.88 % | $ 1.18 B | USA |
 |
Chembio Diagnostics
CEMI
|
2.94 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
13 K | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
-394 K | $ 1.8 | - | $ 7.96 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
857 K | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
337 M | $ 118.45 | 4.04 % | $ 9.77 B |  Irlanda |
 |
Illumina
ILMN
|
-292 M | $ 150.17 | 3.41 % | $ 23.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
6.27 M | - | - | $ 399 M |  China |
 |
Lantheus Holdings
LNTH
|
31.3 M | $ 99.09 | -0.97 % | $ 6.69 B | USA |
 |
Genetic Technologies Limited
GENE
|
17.6 K | - | - | $ 7.1 B |  Australia |
 |
DermTech
DMTK
|
-355 K | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
68.5 M | $ 1 093.84 | -0.68 % | $ 22.5 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
-22.6 M | $ 164.49 | 4.95 % | $ 8.15 B | USA |
 |
NeoGenomics
NEO
|
296 K | $ 9.57 | 3.24 % | $ 1.23 B | USA |
 |
Enzo Biochem
ENZ
|
494 K | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
-5.34 M | $ 428.0 | -0.26 % | $ 12.3 B | USA |
 |
National Research Corporation
NRC
|
-95 K | $ 19.13 | 0.47 % | $ 428 M | USA |
 |
Natera
NTRA
|
9.32 M | $ 203.11 | 1.1 % | $ 20 B | USA |
 |
Exact Sciences Corporation
EXAS
|
18.6 M | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
800 K | $ 3.94 | 2.34 % | $ 365 M | USA |
 |
Personalis
PSNL
|
205 K | $ 9.49 | 6.15 % | $ 847 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
288 M | $ 26.6 | -1.26 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-23 K | $ 6.32 | -1.71 % | $ 264 M | USA |
 |
QIAGEN N.V.
QGEN
|
-6.65 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.58 M | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-903 K | $ 64.17 | -1.08 % | $ 3.84 B | USA |
 |
Biomerica
BMRA
|
367 | $ 2.46 | -0.61 % | $ 5.65 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
224 M | $ 258.25 | -0.08 % | $ 21.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
-12 M | $ 456.21 | 1.79 % | $ 172 B | USA |
 |
Waters Corporation
WAT
|
14.3 M | $ 342.18 | 1.05 % | $ 20.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
6.75 M | $ 0.68 | 5.04 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
211 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
38.1 M | $ 9.2 | 0.66 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
26 M | $ 193.99 | 0.58 % | $ 21.5 B | USA |